Fingerprint
Dive into the research topics of 'Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
Marcia S. Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H. Taylor, Zhuoying Wang, Lori J. Wirth, Francis P. Worden, John Bernard, Paolo Caferra, Raffaella M. Colzani, Shiguang Liu, Martin Schlumberger
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations